Answers are grounded in this paper and cite their sources.
Advances are being made in the management of sickle cell disease for all age groups. This review discusses the progress in amelioration of symptoms, problems unique to particular age groups, and the types of drugs and treatments currently under investigation
No takes yet. Share an insight, caveat, or question.
S. Claster (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: